Skip to main content
Top
Published in: Digestive Diseases and Sciences 4/2023

25-10-2022 | Endoscopy | Original Article

Clinical Outcomes of Patients with Benign Peptic Ulcer Bleeding After an Emergency Endoscopy Based on Patient Location

Authors: Boram Cha, Jin Hee Noh, Ji Yong Ahn, Jun Su Lee, Ga Hee Kim, Hee Kyong Na, Kee Wook Jung, Jeong Hoon Lee, Do Hoon Kim, Kee Don Choi, Ho June Song, Gin Hyug Lee, Hwoon-Yong Jung

Published in: Digestive Diseases and Sciences | Issue 4/2023

Login to get access

Abstract

Background and Aims

In the efforts toward reducing bleeding-related mortality, it is crucial to determine the risk factors for rebleeding after endoscopic hemostasis in benign peptic ulcer (BPU).

Methods

Between 2013 and 2017, the medical records of 864 BPU patients were selected from 5076 who had undergone emergency endoscopy for suspected upper gastrointestinal bleeding. Patients who visited the emergency room or were hospitalized for other illnesses were selected. The primary end point was rebleeding within 30 days after initial endoscopy. The risk factors of rebleeding and subgroup analyses according to patient location were evaluated.

Results

Among 864 BPU bleeding patients, rebleeding after completion of BPU bleeding occurred in 140 (16.2%). Initial indicators of hypotension (OR 1.878, p = 0.005) and Forrest classes Ia (OR 25.53, p < 0.001), Ib (OR 27.91, p = 0.005), IIa (OR 21.41, p < 0.001), and IIb (OR 23.74, p < 0.001) were independent risk factors of rebleeding compared to Forrest class III, and being inpatients (OR 1.75, p = 0.01). Compared to the outpatients, the inpatients showed significantly higher rebleeding rates (25.6% vs 13.8%, p < 0.001), predictive bleeding scores, red blood transfusion counts, proportion of Forrest classes Ia, Ib, and IIb (p < 0.001), and overall mortality rates (68.8% vs 34.0%, p < 0.001).

Conclusions

Patient location was a novel predictive factor of BPU rebleeding. Particularly, being an inpatient correlated with increased rebleeding. Furthermore, Forrest classes Ia, Ib, IIa, and IIb were predictive of rebleeding not only the included BPUs, but also in the inpatient or outpatient groups.
Literature
1.
go back to reference Gralnek IM, Barkun AN, Bardou M. Management of acute bleeding from a peptic ulcer. N Engl J Med. 2008;359:928–937.CrossRefPubMed Gralnek IM, Barkun AN, Bardou M. Management of acute bleeding from a peptic ulcer. N Engl J Med. 2008;359:928–937.CrossRefPubMed
2.
go back to reference García-Iglesias P, Villoria A, Suarez D et al. Meta-analysis: predictors of rebleeding after endoscopic treatment for bleeding peptic ulcer. Aliment Pharmacol Ther. 2011;34:888–900.CrossRefPubMed García-Iglesias P, Villoria A, Suarez D et al. Meta-analysis: predictors of rebleeding after endoscopic treatment for bleeding peptic ulcer. Aliment Pharmacol Ther. 2011;34:888–900.CrossRefPubMed
3.
go back to reference Barkun AN, Bardou M, Kuipers EJ et al. International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med. 2010;152:101–113.CrossRefPubMed Barkun AN, Bardou M, Kuipers EJ et al. International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med. 2010;152:101–113.CrossRefPubMed
4.
go back to reference Sung JJ, Barkun A, Kuipers EJ et al. Intravenous esomeprazole for prevention of recurrent peptic ulcer bleeding: a randomized trial. Ann Intern Med. 2009;150:455–464.CrossRefPubMed Sung JJ, Barkun A, Kuipers EJ et al. Intravenous esomeprazole for prevention of recurrent peptic ulcer bleeding: a randomized trial. Ann Intern Med. 2009;150:455–464.CrossRefPubMed
5.
go back to reference Hreinsson JP, Kalaitzakis E, Gudmundsson S, Björnsson ES. Upper gastrointestinal bleeding: incidence, etiology and outcomes in a population-based setting. Scand J Gastroenterol. 2013;48:439–447.CrossRefPubMedPubMedCentral Hreinsson JP, Kalaitzakis E, Gudmundsson S, Björnsson ES. Upper gastrointestinal bleeding: incidence, etiology and outcomes in a population-based setting. Scand J Gastroenterol. 2013;48:439–447.CrossRefPubMedPubMedCentral
6.
go back to reference Thomopoulos KC, Vagenas KA, Vagianos CE et al. Changes in aetiology and clinical outcome of acute upper gastrointestinal bleeding during the last 15 years. Eur J Gastroenterol Hepatol. 2004;16:177–182.CrossRefPubMed Thomopoulos KC, Vagenas KA, Vagianos CE et al. Changes in aetiology and clinical outcome of acute upper gastrointestinal bleeding during the last 15 years. Eur J Gastroenterol Hepatol. 2004;16:177–182.CrossRefPubMed
7.
go back to reference Marmo R, Koch M, Cipolletta L et al. Predicting mortality in non-variceal upper gastrointestinal bleeders: validation of the Italian PNED score and prospective comparison with the rockall score. Off J Am Coll Gastroenterol ACG 2010;105:1284–1291.CrossRef Marmo R, Koch M, Cipolletta L et al. Predicting mortality in non-variceal upper gastrointestinal bleeders: validation of the Italian PNED score and prospective comparison with the rockall score. Off J Am Coll Gastroenterol ACG 2010;105:1284–1291.CrossRef
8.
go back to reference Chiu PW, Ng EK, Cheung FK et al. Predicting mortality in patients with bleeding peptic ulcers after therapeutic endoscopy. Clin Gastroenterol Hepatol. 2009;7:311–316.CrossRefPubMed Chiu PW, Ng EK, Cheung FK et al. Predicting mortality in patients with bleeding peptic ulcers after therapeutic endoscopy. Clin Gastroenterol Hepatol. 2009;7:311–316.CrossRefPubMed
9.
go back to reference Kim JS, Kim BW, Park SM et al. Factors associated with rebleeding in patients with peptic ulcer bleeding: analysis of the korean peptic ulcer bleeding (K-PUB) Study. Gut Liver 2018;12:271–277.CrossRefPubMedPubMedCentral Kim JS, Kim BW, Park SM et al. Factors associated with rebleeding in patients with peptic ulcer bleeding: analysis of the korean peptic ulcer bleeding (K-PUB) Study. Gut Liver 2018;12:271–277.CrossRefPubMedPubMedCentral
10.
go back to reference Chang DW, Shapiro MF. Association between intensive care unit utilization during hospitalization and costs, use of invasive procedures, and mortality. JAMA Intern Med. 2016;176:1492–1499.CrossRefPubMed Chang DW, Shapiro MF. Association between intensive care unit utilization during hospitalization and costs, use of invasive procedures, and mortality. JAMA Intern Med. 2016;176:1492–1499.CrossRefPubMed
11.
go back to reference Rao VL, Gupta N, Swei E et al. Predictors of mortality and endoscopic intervention in patients with upper gastrointestinal bleeding in the intensive care unit. Gastroenterol Rep. (Oxf) 2020;8:299–305.CrossRefPubMed Rao VL, Gupta N, Swei E et al. Predictors of mortality and endoscopic intervention in patients with upper gastrointestinal bleeding in the intensive care unit. Gastroenterol Rep. (Oxf) 2020;8:299–305.CrossRefPubMed
12.
go back to reference Cipolletta L, Bianco MA, Rotondano G, Marmo R, Piscopo R. Outpatient management for low-risk nonvariceal upper GI bleeding: a randomized controlled trial. Gastrointest Endosc. 2002;55:1–5.CrossRefPubMed Cipolletta L, Bianco MA, Rotondano G, Marmo R, Piscopo R. Outpatient management for low-risk nonvariceal upper GI bleeding: a randomized controlled trial. Gastrointest Endosc. 2002;55:1–5.CrossRefPubMed
13.
go back to reference Forrest JA, Finlayson ND, Shearman DJ. Endoscopy in gastrointestinal bleeding. Lancet 1974;2:394–397.CrossRefPubMed Forrest JA, Finlayson ND, Shearman DJ. Endoscopy in gastrointestinal bleeding. Lancet 1974;2:394–397.CrossRefPubMed
15.
go back to reference Blatchford O, Murray WR, Blatchford M. A risk score to predict need for treatment for upper-gastrointestinal haemorrhage. Lancet 2000;356:1318–1321.CrossRefPubMed Blatchford O, Murray WR, Blatchford M. A risk score to predict need for treatment for upper-gastrointestinal haemorrhage. Lancet 2000;356:1318–1321.CrossRefPubMed
16.
go back to reference Thandassery RB, Sharma M, John AK et al. Clinical application of AIMS65 scores to predict outcomes in patients with upper gastrointestinal hemorrhage. Clin Endosc. 2015;48:380–384.CrossRefPubMedPubMedCentral Thandassery RB, Sharma M, John AK et al. Clinical application of AIMS65 scores to predict outcomes in patients with upper gastrointestinal hemorrhage. Clin Endosc. 2015;48:380–384.CrossRefPubMedPubMedCentral
17.
go back to reference Matsuhashi T, Hatta W, Hikichi T et al. A simple prediction score for in-hospital mortality in patients with nonvariceal upper gastrointestinal bleeding. J Gastroenterol. 2021;56:758–768.CrossRefPubMed Matsuhashi T, Hatta W, Hikichi T et al. A simple prediction score for in-hospital mortality in patients with nonvariceal upper gastrointestinal bleeding. J Gastroenterol. 2021;56:758–768.CrossRefPubMed
18.
go back to reference El Ouali S, Barkun A, Martel M, Maggio D. Timing of rebleeding in high-risk peptic ulcer bleeding after successful hemostasis: a systematic review. Can J Gastroenterol Hepatol. 2014;28:543–548.CrossRefPubMedPubMedCentral El Ouali S, Barkun A, Martel M, Maggio D. Timing of rebleeding in high-risk peptic ulcer bleeding after successful hemostasis: a systematic review. Can J Gastroenterol Hepatol. 2014;28:543–548.CrossRefPubMedPubMedCentral
19.
go back to reference Hsu PI, Lin XZ, Chan SH et al. Bleeding peptic ulcer–risk factors for rebleeding and sequential changes in endoscopic findings. Gut 1994;35:746–749.CrossRefPubMedPubMedCentral Hsu PI, Lin XZ, Chan SH et al. Bleeding peptic ulcer–risk factors for rebleeding and sequential changes in endoscopic findings. Gut 1994;35:746–749.CrossRefPubMedPubMedCentral
20.
go back to reference Lau JY, Sung J, Hill C et al. Systematic review of the epidemiology of complicated peptic ulcer disease: incidence, recurrence, risk factors and mortality. Digestion 2011;84:102–113.CrossRefPubMed Lau JY, Sung J, Hill C et al. Systematic review of the epidemiology of complicated peptic ulcer disease: incidence, recurrence, risk factors and mortality. Digestion 2011;84:102–113.CrossRefPubMed
23.
go back to reference Barkun AN, Almadi M, Kuipers EJ et al. Management of nonvariceal upper gastrointestinal bleeding: guideline recommendations from the International Consensus Group. Ann Intern Med. 2019;171:805–822.CrossRefPubMedPubMedCentral Barkun AN, Almadi M, Kuipers EJ et al. Management of nonvariceal upper gastrointestinal bleeding: guideline recommendations from the International Consensus Group. Ann Intern Med. 2019;171:805–822.CrossRefPubMedPubMedCentral
24.
go back to reference Ebrahimi Bakhtavar H, Morteza Bagi HR, Rahmani F, Shahsavari Nia K, Ettehadi A. Clinical scoring systems in predicting the outcome of acute upper gastrointestinal bleeding; a narrative review. Emergency (Tehran) 2017;5:e36. Ebrahimi Bakhtavar H, Morteza Bagi HR, Rahmani F, Shahsavari Nia K, Ettehadi A. Clinical scoring systems in predicting the outcome of acute upper gastrointestinal bleeding; a narrative review. Emergency (Tehran) 2017;5:e36.
25.
go back to reference Saltzman JR, Tabak YP, Hyett BH et al. A simple risk score accurately predicts in-hospital mortality, length of stay, and cost in acute upper GI bleeding. Gastrointest Endosc. 2011;74:1215–1224.CrossRefPubMed Saltzman JR, Tabak YP, Hyett BH et al. A simple risk score accurately predicts in-hospital mortality, length of stay, and cost in acute upper GI bleeding. Gastrointest Endosc. 2011;74:1215–1224.CrossRefPubMed
26.
go back to reference Sung JJ, Chiu PW, Chan FKL et al. Asia-Pacific working group consensus on non-variceal upper gastrointestinal bleeding: an update 2018. Gut 2018;67:1757–1768.CrossRefPubMed Sung JJ, Chiu PW, Chan FKL et al. Asia-Pacific working group consensus on non-variceal upper gastrointestinal bleeding: an update 2018. Gut 2018;67:1757–1768.CrossRefPubMed
27.
go back to reference Guglielmi A, Ruzzenente A, Sandri M et al. Risk assessment and prediction of rebleeding in bleeding gastroduodenal ulcer. Endoscopy 2002;34:778–786.CrossRefPubMed Guglielmi A, Ruzzenente A, Sandri M et al. Risk assessment and prediction of rebleeding in bleeding gastroduodenal ulcer. Endoscopy 2002;34:778–786.CrossRefPubMed
Metadata
Title
Clinical Outcomes of Patients with Benign Peptic Ulcer Bleeding After an Emergency Endoscopy Based on Patient Location
Authors
Boram Cha
Jin Hee Noh
Ji Yong Ahn
Jun Su Lee
Ga Hee Kim
Hee Kyong Na
Kee Wook Jung
Jeong Hoon Lee
Do Hoon Kim
Kee Don Choi
Ho June Song
Gin Hyug Lee
Hwoon-Yong Jung
Publication date
25-10-2022
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 4/2023
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-022-07708-0

Other articles of this Issue 4/2023

Digestive Diseases and Sciences 4/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.